Objective: The use of mesenchymal stem cells (MSCs) for cartilage regeneration is hampered by lack of knowledge about the underlying molecular differences between chondrogenically stimulated chondrocytes and MSCs. The aim of this study was to evaluate differences in phenotype and gene expression between primary human chondrocytes and MSCs during chondrogenic differentiation in three-dimensional (3D) pellet culture (PC). Materials and methods: Chondrocytes isolated from cartilage samples obtained during total knee alloarthroplastic procedure (N ¼ 8) and MSCs, purified from bone marrow aspirates of healthy donors (N ¼ 8), were cultivated in PC under chondrogenic conditions. Immunohistology and quantitative reverse transcribing PCR (RT-PCR) were performed for chondrogenic-specific markers (i.e., Sox9, Collagen II). Global gene expression of the so-cultivated chondrocytes and MSCs was assessed by a novel approach of microarray-based pathway analysis. Refinement of data was done by hypothesis-driven gene expression omnibus (GEO) dataset comparison. Validation was performed with separate samples in transforming growth factor (TGF)bþ or TGFbÀ conditions by use of quantitative real-time RT-PCR. Results/conclusions: Chondrogenic commitment of both cell types was observed. Interestingly, chondrocytes demonstrated an upregulated fatty acid/cholesterol metabolism which may give hints for future optimization of culture conditions. The novel microarray-based pathway analysis applied in this study seems suitable for the evaluation of whole-genome based array datasets in case when hypotheses can be backed with already existing GEO datasets. Future experiments should further explore the different metabolic behaviour of chondrocytes and MSC.
Introduction
Osteoarthritis (OA) constitutes a major health problem and biological, non-endoprosthetical osteochondral joint reconstruction remains a yet unsolved task in the interdisciplinary field of cartilage and bone tissue engineering research. Regenerative therapy of OA joints has to focus on several features of the disease 1,2 , e.g., mechanical imbalance and biological alterations (chondrocyte senescence or apoptosis, decreased synthesis of cartilage matrix proteins, inflammation).
While some of those issues can be addressed surgically and pharmacologically, a major challenge remains the regeneration of damaged cartilage by tissue engineering strategies. Although chondrocytes derived from osteoarthritic donors can be used for cartilage tissue engineering, their limited availability, quantity, and viability depict major drawbacks 2 . The use of alternative cell types with chondrogenic differentiation potential may offer a solution. Mesenchymal stem cells (MSCs) have shown to be able to differentiate into cartilage 3, 4 . However, recent data gives conflicting results concerning mechanical quality of MSC-derived cartilage constructs, suggesting inferior properties of chondrogenic differentiated MSCs 5e7 . Interestingly, MSCs only exhibit inferior compressive properties, while tensile properties do not seem to differ from chondrocytes 6, 8 . The amount of produced extracellular matrix varies interindividually and depends on the scaffold matrix used for tissue engineering 7 . Beside the evaluation of these mechanical facts, a detailed subcellular and phenotypic comparison of MSCs with chondrocytes is missing.
Apart from the cellular source, a key factor for successful cartilage tissue engineering is three-dimensional (3D) cultivation.
Chondrocytes undergo rapid dedifferentiation when cultivated in a two-dimensional (2D) environment. Sustained chondrogenic differentiation can only be achieved by the embedding of cells into biomaterials or by material-free pellet culture (PC) 9, 10 .
PC is a matrix-free 3D cultivation method which has shown to elicit a considerable chondrogenic effect on chondrocytes and MSCs 9, 11, 12 .
The aim of the study was to compare temporal global gene expression patterns of PC-conditioned human primary chondrocytes vs human bone marrow-derived MSCs using microarray-based global gene expression analysis. As major drawbacks of microarray experiments are the questionable biological relevance of their results at considerable high costs we figured out a new approach to cope with those issues 13 . To pave the way for further experiments we wanted to exemplify the validation of our data in transforming growth factor (TGF)bþ or TGFbÀ conditions. TGFb is a potent stimulator of collagen biosynthesis, extracellular matrix (ECM) accumulation as well as mesenchymal cell proliferation and activation 14 . It therefore can possibly pronounce pro-chondrogenic effects. In accordance to our previous work we chose TGF-b3 for our experiments 9, 15 .
Materials and methods
All experiments using OA cartilage tissue were approved by the local institutional review board (IRB) (protocol number: EK264122004). MSCs were obtained from the Medical clinic of the university hospital for which a separate IRB vote exists. All patients' material was obtained after informed consent.
Isolation and culture of cells
Primary chondrocytes were obtained from osteoarthritic knee joints during alloarthroplastic procedures from five female patients (mean age 74 years, range 61e85 years) for microarray experiments and from one male and two female patients (mean age 55, range 48e60 years) for polymerase chain reaction (PCR) validation experiments. MSCs were isolated from iliac crest bone marrow from five healthy female donors (mean age 45 years, range 42e48 years) for the microarray experiments and from one male and two female healthy donors (mean age 54 years, range 42e71 years) for PCR-validation experiments.
Chondrogenic commitment of the cells used was proofed by quantitative RT-PCR analysis (Suppl . Table I ).
Chondrocytes were isolated by collagenase (Collagenase Type I, Worthington; Cat.No: CLS1) digestion overnight and expanded in Dulbecco's modified eagle medium (DMEM, Low Glucose, 1x, Invitrogen, Germany) supplemented with 10% fetal calf serum (FCS); 1% Penicillin/Streptomycin. Ficoll-gradient separated MSCs obtained from iliac crest-harvested bone marrow aspirates were kindly provided by Prof. Martin Bornhäuser. FACS analysis revealed positivity for CD166, CD105, CD73, CDw90 (all 99%) and CD146 (30e60%) and negativity for CD45, CD34 and CD14 (data not shown). Passage 0 primary chondrocytes and MSCs, respectively, were used for the experiments.
Pellet culture (PC)
P0-cells were cultured in high-density PCs, as described previously 9 . Briefly, 1.5 Â 10 6 cells were placed into a conical polypropylene tube in chondrogenic medium (see below). The cells were centrifuged at 400 Â g for 10 min. Cell pellets were cultured in DMEM with 1% ITS (Insulin-Transferrin-Selenium 100x, Invitrogen, Germany), 100 U/ml penicillin, 100 mg/ml streptomycin, 210 mmol ascorbic acid, 10 nmol dexamethasone (SigmaeAldrich, Germany) and 10 ng/ml TGF-ß3 (Strathmann Biotec, Germany) at 37 C, 5% CO 2 with medium changes performed every third day. For PCRvalidation experiments, cells were cultivated in the presence or absence of TGF-ß3 (TGF-bþ/TGF-bÀ).
Histology
For histological analysis, pellets cultured for 2 weeks were fixed with paraformaldehyde (1%), dehydrated, paraffin-embedded and cut into slices of 1 mm thickness. Immunohistology was performed using the following antibodies: Collagen I (Clone: COL-1, #C2456, Sigma, Germany), 1:200; Collagen II (Clone: 2B1.5, #MS-235-P, ThermoScientific, Germany), 1:200; Collagen X (Clone: COL-10, #C7974, Sigma, Germany), 1:500; Sox9 (polyclonal, #AB5535, Chemicon, Germany), 1:100.
After detection with the appropriate biotinylated secondary antibody and AB-complex (ABC Standard Kit, Linaris, Germany), Romulin AEC Chromogen kit (Zytomed, Germany) was used for staining. All antibodies were test-run with positive controls, every section was accompanied by a negative control (without primary antibody) to rule out unspecific effects.
Histology results were backed by quantitative reverse transcribing PCR (RT-PCR) data (Suppl. Table I ).
Isolation of RNA
Total RNA was extracted after 0, 3, 7 and 14 days using a twostep extraction protocol as described by Hoemann et al. 16 . Briefly, one pellet sample was mixed with 350 ml of RLT-b-mercaptoethanol solution (RNeasy kit, Qiagen, Germany) and incubated for 30 min at 4 C in a thermomixer shaking vigorously. After centrifugation at 15,000 Â g for 10 min at 4 C the procedure was repeated adding 250 ml of RLT-b-mercapto-ethanol solution followed by a centrifugation step at 21,000 Â g for 10 min. Both supernatants were mixed and the RNeasy procedure was carried out as described by the manufacturer.
Microarray analysis
RNA samples from all five patients of each group were pooled to obtain sufficient material for further analysis and to mitigate for interindividual variations. Gene expression profiling was performed using N ¼ 8 HG-U133 Plus 2.0 arrays (Affymetrix, Santa Clara, CA, USA). Furthermore biotinylated antisense cRNA was prepared according to the Affymetrix standard labelling protocol. Afterwards, the hybridization was performed using a GeneChip Hybridization oven 640, subsequently dyed in a GeneChip Fluidics Station 450 and thereafter scanned with a GeneChip Scanner 3000 (all hardware from Affymetrix, High Wycombe, UK).
A Custom CDF (Chip Definition File) Version 10 with Entrezbased gene definitions was used to annotate the arrays. The Raw fluorescence intensity values were normalized applying quantile normalization method, using a commercial software package SAS JMP7 Genomics, version 3.1, from SAS (SAS Institute, Cary, NC, USA).
All gene expression values were calculated as ratios of the same cell type relatively to day 0. The raw and normalized data is deposited in the Gene Expression Omnibus (GEO) database (http:// www.ncbi.nlm.nih.gov/geo/; accession No. GSE19664).
PCR experiments
RNA was reverse transcribed into cDNA using the Omniscript RT-Kit (Qiagen, Germany) and dT 18 -oligonucleotides.
Quantitative PCR experiments were performed on days 7 and 14 on a MX4000 Multiplex Quantitative PCR machine (Stratagene, The Netherlands) using the appropriate PCR kits (Brilliant Multiplex and SYBR green Master Mix) and selected oligonucleotides (sequences can be obtained from the author). The reaction protocol included an initial denaturation step for 10 min at 95 C which was Table I Gene list 1 after trend-analysis: Analysis path A: initial change from day 0 to day 3 of at least AE2 0,5 and continuous up-or downregulation, differing from the other cell type. Analysis path B: threshold was set to zero; only those genes showing permanent departure in one distinct direction (up or down) contrasting to the curve of the other cell
followed by 40 cycles (30 s 95 Ce1 min 60 Ce30 s 72 C). Quantification was carried out in duplicates, gene transcription was normalized to the GAPDH-value of the same experiment and time point. PCR reactions were carried out in a Stratagene Real-Time PCR System.
Data analysis
Data analysis was splitted in a screening process (Microarray step ¼ gene list 1), interpretative analysis against GEO datasets (gene list 2) and a quantitative validation step via quantitative RT-PCR. The whole analysis process is outlined in Fig. 1 .
Gene list 1: microarray data trend-analysis
Gene expression dynamics were analyzed from day 3 to day 14 as follows. All genes with an initial fold-change in expression from day 0 to day 3 of at least >2 0,5 were included for further analysis. Curves were classified as either constantly upregulated, constantly downregulated, or not constantly (¼unsteady) regulated. If curve classification revealed inequality between MSCs and chondrocytes (e.g., MSC ¼ up, chondrocytes ¼ unsteady) the respective gene was added to gene list 1 ( Fig. 1, path A) . Curves of the genes not fulfilling the initial threshold of 2 0,5 but showing constant dissimilarity of both curves (e.g., MSC ¼ up, chondrocytes ¼ down) were also added to gene list 1 ( Fig. 1, path B ). Genes were annotated to functionally distinct groups by use of gene ontology (GO) terminology.
Gene list 2: trend comparison
Biologically relevant background data was retrieved by a GEO search that included keywords such as "chondrocyte" or "MSC". GEO profile datasets were required to represent a time-based observation under standardized culture conditions. It therefore resulted in a panel of GEO datasets covering processes of mesenchymal limb bud development, tissue engineering, and regeneration after injury (see Table II ).
Regulation curves of the genes in gene list 1 (Table I) were manually compared with the respective gene regulation of the selected GEO dataset from Table II . It was decided, if the curve trend fitted to the MSC or the chondrocyte behaviour. In cases with multiple differently regulated samples, even a both-like (MSC and chondrocyte) behaviour could be attested. Qualifying genes were added to gene list 2 (Table III) . Otherwise genes were given the status "no similarity". If the specific gene was not present in the GEO dataset, the status "not available (NA)" was given.
Validation step: PCR quantification and statistics
Functionally distinct genes from gene list 2 ( Fig. 1 ) were further analyzed via quantitative RT-PCR method. All primers used were validated for specificity by gel electrophoresis of their respective products (data not shown). Data is presented as means. Statistical significance was calculated with ANOVA, using SPSS Ò 17 (SPSS Inc., Chicago, US). P-values < 0.05 were considered significant.
Results
Immunohistology PC-conditioned chondrocytes showed Sox9-expression comparable to MSCs with a trend towards more intranuclear retention Validation was carried out by quantitative RT-PCR of the respective genes and showed a significant higher Sox9-expression in chondrocytes, whereas collagen type I, II and X did not differ significantly (Suppl . Table I ).
Microarray analysis
Whole-genome expression data were compared between chondrocytes and MSCs at various time points (days 0, 3, 7, 14, Fig. 3 , line A). Most similarity, i.e., 95%, of genetic expression between MSCs and chondrocytes existed at time point zero (start). During cultivation cell type-specific differences were observed, reducing similarity to 92% at day 14.
When comparing monolayer-cultivated P0-MSCs (MSC, day 0) with different stages of chondrocyte pellet redifferentiation (days 3, 7, 14, Fig. 3 , line C), decreasing similarity from 95% down to 83% Fig. 3, line B) , the gain of difference between both cell types was smaller (compare lines C vs B), ranging from 95% down to 90% similarity. Microarray data trend-analysis was done as shown in Fig. 1 . Data reduction using path A resulted in 95 genes (gene list 1, see Table I) , of which most belonged to lipid/cholesterol pathway, actin and integrin pathway as well as to vesicle transport systems.
Applying path B resulted in 12 genes, belonging to integrins, sperm and lipid metabolism. The gene brain expressed, X-linked 1 (BEX1) is represented in both analysis pathways as it shows characteristics of path A and B.
Most genes of gene list 1 demonstrate a final gene expression increase in chondrocytes during pellet cultivation (Fig. 4) .
GEO trend comparison
GEO database search resulted in five datasets which are described more precisely in Table II. One hundred and seven genes from gene list 1 were manually compared with the trends of the genes or their homologues in the mentioned datasets. It could be demonstrated that in the group "differentiating limb buds" (GDS1865) 45 genes showed similar regulation to either MSCs or chondrocytes or both; in the group "confluently growing MSCs" (GDS3062) there were 62 genes showing similar patterns. In the groups "retina regeneration" (GDS1404) and "muscle regeneration" (GDS234) only nine and 30 genes, respectively, showed a similar regulation. The group "neuronal regeneration" (GDS63) resulted in 15 comparable genes. Due to this low sample size, further analysis within this group was not carried out.
The result of the similarity of chondrocytes and MSCs with GEO datasets in temporal gene expression levels is summarized in gene list 2 (Table III) .
A minimum of one gene out of each functional group, occurring in more than one GEO datasets and matching to chondrocyte or 
PCR quantitative analysis
Regardless of TGFb supplementation, aggrecan (ACAN1) expression levels were approximately 20e30-fold increased in chondrocytes compared to MSCs in the first and second weeks of cultivation ( Fig. 5 ). Of all the other genes, only inhibitor of DNA binding (ID4) was expressed significantly (30-fold) by chondrocytes and MSCs after 2 weeks of cultivation with TGFb.
Low-value-difference patterns were visible for chloride intracellular channel 4 (CLIC4), being expressed 1,1e1,5-fold (week 1eweek 2, TGFbþ) or 2,1e2,6-fold (TGFbÀ) higher in chondrocytes, reaching significance only in the TGFbÀ group. A similar trend could be observed for the 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (HMGCS1), which was 1,1e1,6-fold (TGFbþ) or 2,1e2,8-fold (TGFbÀ) higher in chondrocytes, although only close to significance.
Significant upregulation could be seen in the chondrocytic ADAM metallopeptidase (ADAMTS5) only under TGFbÀ conditions (2,3e2,8-fold), in the first-week chondrocytic nicotinamide nucleotide transhydrogenase (NNT, 2,1-fold) and in the second-week chondrocytic cytochrome P450 oxidase (CYP51A1, 3,7-fold).
The chondrocytic gene popeye domain containing 3 (POPDC3) showed a significant reduction of expression in the second week under TGFb-stimulation to 30% of the MSC-value.
The other genes were low and not significantly regulated ( Fig. 5 ).
Of the significantly regulated genes, chondrocytic aggrecan (ACAN1) and POPDC3 showed the least sensitivity to TGFb-regulation, whereas a reduction of chondrocytic CYP51A1 (0,77-fold), CLIC4 (0,56-fold), NNT (0,54-fold), ADAMTS5 (0,4-fold) and ID4 (0,09-fold) could be observed (Fig. 5 ).
Discussion
In the field of cartilage tissue engineering there is a major need for a sufficient yield of cells. Since healthy cartilage offers only 5% cells/volume, an even lower amount of chondrocytes is usually harvested from diseased joints 17 . MSC has shown to possess suitable chondrogenic potency 18 . However, MSC-derived chondrocytes show inferior mechanical properties and produce less extracellular matrix proteins compared with primary chondrocytes 19 .
We therefore investigated whether we could depict gene expression differences between chondrocytes and MSCs during chondrogenic redifferentiation by PC.
Commitment to chondrogenic differentiation
We have started our experiments by confirming chondrogenic commitment of PC-conditioned chondrocytes and PC-conditioned MSC immunohistologically and by quantitative RT-PCR analysis of Sox9, collagen type I, II and X.
Chondrocytes and MSC, showed a ready progression towards the chondrogenic lineage. Sox9-expression was higher in chondrocytes accompanied by an immunohistological notion of more intranuclear retention. Although there were no significant differences in collagen I and II mRNA expression, our data suggests that MSC's may be less efficient at translating, processing or incorporating collagen into the extracellular matrix.
Chondrogenic arrest is missed and both cell types proceed towards hypertrophy. This, being a still unsolved major drawback of in vitro culture systems, has been described before in more detail 19, 20 .
Analysis strategy
Classical ways of microarray analysis use a number of replicates for each study point and try to filter biological information in a more or less computed fashion 21 . The involved procedures rely on statistical methods that are still flawed by difficulties (e.g., multiple testing) and uncertainties about the biological relevance of the results 13, 22 . Alternatively, we used a serial approach, including microarray-screening, GEO-comparison and PCR validation of candidate genes (Fig. 1 ). As the microarray data is retrieved through pooling of samples, statistical relevance cannot be calculated. Hence, this denotes a potential limitation of the study that was dealt within the further experimental design. First, biological variation was already incorporated through the pooling of samples. Second, we underweighted microarray data and did not attempt to implement statistical safety in the beginning. We used the two microarray "clouds" of chondrocyte and MSC behaviour to filter out the differences. Omitting doubtful statistical procedures had the advantage of gaining a high sensitivity in the screening process. Low specificity is raised in a step-wise manner as described in the methods section. We analyzed the microarray data against an arbitrarily selected, biologically relevant background of regenerative processes, assessed through carefully conducted microarray experiments. In contrast to a non-hypothesis-driven analysis, often performed in whole-genome expression analysis experiments, we generated hypotheses for every GEO dataset ( Table. II) . Notably, this approach facilitated to narrow the scope of candidate genes and allowed for the interpretation from a system-biological point of view. However, there are clear limitations: hypothesis-driven microarray analysis only works when statistically safe background data is available.
Result of hypothesis testing
For example, in contrast to the initial hypothesis, chondrocyte PC resembled limb bud outgrowth 23 more likely than MSC did. Regulatory similarities were more likely to be seen in chondrocytic PC and were more closely related to the chondrogenic pathway. Another hypothesis e MSC PCs would be closer related to 2D-MSCs reaching confluence e was also falsified: 2D-expansion of MSCs resembled changes occurring in chondrocytic PCs more likely than in MSC PCs.
This accounts especially for differences that were validated for the cholesterol pathway and for chondrogenic marker genes. One might be tempted to accuse the high-serum conditions used in the reference experiment "confluently growing MSCs" 24 to explain the unexpected similarity between cell layer-cultivated MSC and chondrocytes cultured in 3D PC.
To gain more insight into the validity of the observed trends, validation experiments were performed using quantitative RT-PCR.
Triggers of chondrogenic effects
In contrast to the observed phenotypic and functional differences, chondrocytes expressed significantly more aggrecan compared with MSCs. This has not been shown before quantitatively. Supposedly to support aggrecan production, the aggrecanase ADAMTS5 was downregulated in chondrocytes. This occurred only under the influence of TGF-b as has been shown before 25e27 and correlates well with other already described pro-chondrogenic effects of TGF-b, e.g., its chondro-protective effect in osteoarthritic joints 28 , its role in preventing terminal endochondral differentiation 29 , and its beneficial use in cartilage tissue engineering 30 .
TGF-b-driven effects denote an example of the sensitivity of cellbased constructs towards culture conditions.
Although not included in RT-PCR-validation, chondrocytic upregulation of the glucosaminyltrans-ferase MGAT4B demonstrated the increased glycano-anabolic activity in chondrocytes when compared with MSCs.
Fatty acid metabolism and cholesterol biosynthesis
Most strikingly, chondrocytes showed an upregulated fatty acid metabolism (CYP51A1, FADS3, SMPDL3A) and cholesterol-/sterol biosynthesis-pathway (FDFT1, FDPS, HMGCS1, LDLR, SC4MOL, SC5DL, SQLE) in the microarray-screening. Chondrocytic upregulation was validated for HMGCS1 and the cytochrome P450 oxidase CYP51A1, thus verifying an increased cholesterol-biosynthetic activity in chondrocytes.
This phenomenon was discovered earlier as a specific feature of growth plate chondrocytes 31 . The importance of the cholesterolbiosynthetic pathway for chondrocyte and limb bud development has been demonstrated by linking it to hedgehog signalling 32e34 , nuclear receptor roralpha 35 and to liver X and retinoid receptors 36 . MSCs, however, do not upregulate their cholesterol biosynthesis, which could be interpreted as a hint that their original cellular signalling context is located farther away from the joint line e more towards bone 37 .
MSC in their relation to bone
Osteoprotegerin (TNFRSF11B) upregulation underlines the specific feature of MSCs to readily undergo osseous differentiation 38, 39 . Compared to chondrocytes, their suitability for a regenerative cartilage therapy seems therefore to be limited e at least under the conditions used in our experimental setting.
Other differences between chondrocytes and MSC

ID-Proteins function as Corepressors by binding of Helix-Loop-
Helix motifs of tissue-specific transcription factors. Higher expression of the inhibitors of DNA binding ID3 and ID4 in MSCs e as was detected in our experiments e can be indicative for a sustained undifferentiated state 40 .
Downregulation of the eukaryotic translation initiation factor EIF2AK4 marks an increase of protein biosynthesis in MSCs 41 . Proenkephalin (PENK) and endothelial PAS domain protein 1 (EPAS1) are hypoxia-responsive genes that support angiogenesis 42 . This seems to be an answer of oxygen-deprived MSC (due to PC condition) that cannot be seen in chondrocytes.
Chondrocytes expressed more of the intracellular chloride channel CLIC4, a conserved gene among vertebrates. CLIC4 was shown to be a mediator of TGF-b signalling via its translocation to the nucleus. Although its function is not yet clear, it seems to have some relevance in endothelial tubule formation, anti-apoptotic action and fibroblast-to-myofibroblast-transdifferentiation in cancer cells 43, 44 . Despite its primary description as an intracellular channel, involvement in cellular volume regulation could be a function of the untranslocated protein 45 .
Conclusion
Phenotype and gene expression of chondrocytes and MSCs differ during chondrogenic PC. Our data suggests, that MSC in simple PC do not seem to reach the same stage of chondrogenic differentiation as chondrocytes do, regardless of TGFb-supplementation and despite harvesting from younger and healthier donors. Most strikingly, MSCs show a reduced expression of chondrogenic matrix proteins, e.g., collagen II and aggrecan. On the other side, MSCs are more rapidly prepared for an osseous transformation. A specific metabolic aspect of chondrocytes, that has not been described in comparison with MSCs before, is their upregulated fatty acid/cholesterol biosynthesi-pathway. This pathway may be a potential target for optimization of chondrogenic MSC culture conditions. We interpreted our data in the background of already existing datasets, thus bringing it closer to biological relevance. This may be an advantageous choice in cases when hypotheses can be backed by already existing expression data. However, this might not be the case for other situations when such data does not exist and statistical safety is important to the whole-genome dataset.
Future experiments should explore the different metabolic behaviour of chondrocytes and MSC and their biological relevance.
